Translate AMICOR contents if you like

Sunday, May 15, 2016

Endoplasmic reticulum disfunction

New tool identifies novel compound targeting causes of type 2 diabetes

For immediate release: June 17, 2015
BOSTON — A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound—and a powerful way to quickly test whether other molecules can have a positive effect on a critical molecular pathway believed to be central to diseases ranging from diabetes to retinitis pigmentosa, cystic fibrosis, Huntington’s disease, and Alzheimer’s.
The study appears in the June 17, 2015 issue of Science Translational Medicine. (The animation at the top of the page depicts how dysfunction in the endoplasmic reticulum leads to diabetes.)/.../

No comments: